See the DrugPatentWatch profile for cosentyx

The exact dosage of Cosentyx (secukinumab) for psoriasis injections is 300 mg. This dose is administered via subcutaneous injection, and it is typically given initially as two doses, one week apart, followed by a maintenance dose every four weeks [1]. However, it is important to note that the specific dosage can vary depending on the individual's body weight, the severity of their psoriasis, and the patient's response to treatment. Therefore, it is essential to consult with a healthcare professional for personalized dosage information.

It is also worth noting that, according to DrugPatentWatch.com, Cosentyx is a brand-name prescription medication that is used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. The drug is manufactured by Novartis Pharmaceuticals Corporation, and it was first approved by the FDA in 2015 for the treatment of moderate-to-severe plaque psoriasis [2].

In summary, the exact dosage of Cosentyx for psoriasis injections is 300 mg, administered via subcutaneous injection. However, the specific dosage can vary depending on individual factors, so it is essential to consult with a healthcare professional for personalized dosage information.

Sources:

1. Cosentyx (secukinumab) [Prescribing information]. (2021). Novartis Pharmaceuticals Corporation. Retrieved from <https://www.novartis.com/sites/www.novartis.com/files/cosentyx.pdf>
2. Cosentyx (secukinumab) [DrugPatentWatch]. (n.d.). DrugPatentWatch. Retrieved from <https://www.drugpatentwatch.com/drugs/cosentyx>